BMS recruiting 400 for new biologics plant in Dublin
The global biopharma company, BMS, which focuses on helping patients prevail over serious illness, is growing operations, constructing a new manufacturing plant at the Cruiserath facility, Dublin. This will be the first time in BMS’s history that biologics manufacturing will be taking place outside of the US.
In line with this expansion, BMS will be hiring for 400 new roles between now and 2018. The company will be seeking highly-skilled bioprocess engineers and biologists, explained Cahill.
Almost as important as qualifications, however, are behaviours. BMS looks for candidates who are intellectually curious, collaborative and easily adaptable, and who show energy and enthusiasm. An interest in learning, developing and growing within BMS is an advantage.
Bristol-Myers Squibb is a global BioPharma company firmly focused on its Mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. BMS employs over 27,000 people worldwide, and approximately 550 people in Ireland in its Global Manufacturing and Supply (GMS) and Commercial operations.
